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Abstract 
Background: Preterm birth has been linked to increased risk of autism spectrum disorders 
(ASD), but how this risk changes with gestational age at birth has not been well-characterized, 
especially with regard to co-occurring intellectual disability (ID).  
Methods: Register-based cohort study of singleton births in 1984-2007 in Stockholm County, 
Sweden (N total: 480,728; n ASD: 10,025). We assessed overall and sex-specific gestational 
week specific prevalence estimates and risk ratios of ASD with and without ID. 
Results: Preterm and postterm births were associated with elevated risk of ASD, and the 
relationship between gestational age at birth and ASD with and without ID differed in males and 
females. Risk of ASD without ID was higher in preterm births among both sexes and decreased 
continuously with increasing length of gestation. Risk of ASD with ID was higher in both 
preterm and postterm births among both sexes, with postterm birth in females being more highly 
associated with ASD with ID than that in males. 
Conclusions: The relationship between gestational age at birth and ASD differs by the 
presence/absence of co-occurring ID and fetal sex. Both preterm and postterm birth are 
associated with increased risk of ASD. Risk of ASD is not constant within conventionally 
defined gestational age at birth periods. Further research on mechanism underlying these 
associations is needed. 
 
 
Keywords: Autism Spectrum Disorders; Intellectual Disability; Gestational Age; Pre-term; Post-term; 
Generalized Additive Model  
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Introduction 
Autism spectrum disorders (ASD) are early-onset neurodevelopmental conditions with diverse 
behavioral presentations and multifactorial etiology.1 ASD can be reliably diagnosed by two 
years of age.1 It has been suggested that the development of ASD without co-occurring 
intellectual disability (ID, defined as IQ < 70) may involve a stronger familial component than 
that of ASD with ID.2 Influences on the gestational environment, including fetal growth 
deviance,3 infection,4 inflammation,5 and maternal exposure to environmental toxins6 have been 
proposed to play a role in the etiology of ASD and co-occurring ID. In a recent study of a 
Stockholm-based cohort, we estimated that approximately 26% of those with ASD have co-
occurring ID.7 The presence/absence of ID is considered to be the most critical factor affecting 
outcomes in this population.8 
 
Gestational age at birth measures the duration of pregnancy and also is an established indicator 
of fetal growth maturity at birth. Preterm (gestational age at birth < 37 weeks) and postterm 
(gestational age at birth ≥ 42 weeks) births account for about 10% and 7% of all births 
worldwide, respectively.9,10 Although the causes of preterm and postterm births have not been 
fully identified, genetics, maternal reproductive history, maternal health before and during 
pregnancy, as well as child characteristics including fetal sex have been reported to influence 
pregnancy duration.9–12 Both preterm and postterm births have been linked to elevated risk of 
ASD. For example, one Danish population-based study of over 1.7 million births reported that 
compared to individuals born at 40 weeks, the risk of ASD among those born at 24-27 weeks and 
42-43 weeks were 3-14.7 and 1.0-1.2 times higher, respectively.13 A recent meta-analysis 
identified 14 original research articles investigating the association between postterm birth and 
risk of ASD.14 Of these, 7 reported null findings, 6 reported a positive association, and 1 reported 
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a negative association. The pooled estimate suggested a slight increase in relative risk (RR) of 
ASD associated with postterm birth, although the 95% confidence interval (CI) was wide (RR 
1.14; 95% CI: 0.58, 2.24). Furthermore, phenotypic differences by sex have been noted in 
ASD,15 and pregnancies with boys tend to be shorter.11 However, prior investigations have not 
examined how associations may differ by sex for ASD with and without co-occurring ID in a 
large sample.16–18 
 
Though the relationship between preterm birth and risk of ASD has been suggested with 
categorical parametrizations of gestational age,14 less is known about how risk of ASD changes 
across the full range of gestational age, especially among postterm births. In this study, we 
investigated the association between gestational age at birth and ASD with and without ID, and 
estimated overall and sex-specific prevalence at each week of gestational age at birth for 
deliveries at 27-43 weeks, using data from a large Swedish population-based record-linkage 
study. We hypothesized that the relationship between gestational age at birth and ASD without 
ID would be different from that between gestational age at birth and ASD with ID, and these 
relationships might be different in males and females.  
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Methods 
Study population 
This study was nested within the Stockholm Youth Cohort, an ongoing longitudinal register-
linkage cohort study of the total child population aged 0-17 years residing in Stockholm County, 
Sweden, who were born between 1984 and 2007. The last follow-up date in the study period was 
December 31, 2011. A full description of the Stockholm Youth Cohort design is available 
elsewhere.19 Data on ante- and perinatal factors were obtained from the Swedish Medical Birth 
Register (MBR). Diagnoses of ASD and ID were ascertained using International Classification 
of Diseases (ICD) and Diagnosis and Statistical Manual of Mental Disorders (DSM) codes (ASD: 
ICD-9 299, ICD-10 F84, DSM-IV 299; ID: ICD-9 317–319, ICD-10 F70–F79, DSM-IV 317–
319) and health services usage records from birth to the latest register update in December 2011. 
Family relations were identified from the Multi‐Generation Register. Demographic and financial 
data were obtained from the Integrated Database for Labor Market Research. Ethical approval 
was obtained from the research ethics committee at Karolinska Institutet. 
 
We examined singleton live births with complete data on ASD, ID, gestational age at birth and 
sex (Ntotal = 480,852, NASD = 10,029). Data on all other variables except maternal smoking were 
complete. Maternal smoking data were available for 90% of individuals. Figure 1 shows the 
derivation of the study sample. Because perinatal risk profiles including mortality, gestational 
age at birth and birthweight are very different between singleton and multiple births,1 we 
excluded multiple births from the study. Additionally, we excluded 137 individuals with 
improbable birthweights using methods we have applied in a previous study.20 
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Variables 
Gestational age, gestational diabetes, hypertension, parity, birthweight and maternal smoking 
were obtained from the MBR. The MBR uses information from several variables to 
hierarchically determine gestational age—first from ultrasound-based estimate, then from date of 
last menstrual period, pediatric record, and birthweight. About 90% of gestational age at birth 
data on births during our study period were based on ultrasound results, followed by about 8% 
that were based on date of last menstrual period.21 Gestational age in weeks rounded to the 
nearest tenth was used in the analysis. Gestational diabetes (ICD-10 O24.4, ICD-9 648W) and 
hypertension (ICD-10 I10-I13 and O10-O11, ICD-9 401-404, 642A-642C, ICD-8 400, 401, 402, 
403, 404) were identified using ICD codes.19 Parity was categorized as 1, 2 and ≥ 3 in the 
analysis. Birthweight-for-gestational age z-scores were calculated from birthweight and 
gestational age at birth data using separate national references for boys and girls.3 Paternal and 
maternal ages at delivery were calculated based on each parent’s date of birth. Parental history of 
neurologic and psychiatric disorders data were extracted from regional and national registers as 
previously described and coded as one binary variable (yes/no history) for each parent.22 
Disposable family income data were obtained from the Integrated Database for Labour Market 
Research, were adjusted for family size and inflation and accounted for all sources of income. 
This variable was categorized into quintiles based on national data.22 Maternal country of birth 
data were obtained from the Total Population Register and was categorized as mother “born in 
Sweden”, “in another European country, or “outside Europe”. Maternal self-reported smoking 
during pregnancy were obtained from the MBR and were categorized as “yes”, “no” or 
“unknown”. 
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Statistical analysis 
We used cubic splines in generalised additive models (GAM) to model the association of 
gestational age at birth with the risk of ASD,23 adjusting for potential confounders identified a 
priori from the literature.6,14,24 Covariates included in the GAM were: sex-adjusted birthweight-
for-gestational age z-scores, offspring sex, birth year, paternal and maternal ages and their 
interaction22, maternal smoking, paternal and maternal neuropsychiatric histories, parity, 
gestational diabetes, hypertension, family income quintiles and maternal country of origin. We 
included a random intercept for sibship in the model to account for clustering of unmeasured 
familial components in ASD25, preterm12 and postterm26 birth, and conducted a sensitivity 
analysis only on non-siblings, (i.e., one child from each family was chosen at random to be 
included in this analysis), using the same variables and model specifications as those used in the 
analysis of the total sample. Sex-specific associations were assessed using the likelihood ratio 
test comparing nested models with and without an interaction term between sex and gestational 
age. In sex-stratified analyses, we used the same model specification to estimate the association 
of gestational age at birth and risk of ASD with and without co-occurring ID separately in males 
and females. From expected probabilities of ASD based on the multivariable GAM model, we 
calculated gestational age at birth--specific prevalence proportions associated with each week. 
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Results 
Sample characteristics 
The study sample included 480,728 individuals. A total of 10,025 (2.1%) persons were 
diagnosed with ASD; of these, 2,368 (23.6%) and 7,657 (76.4%) were diagnosed with and 
without co-occurring ID, respectively.  
 
There were some differences in sample characteristics by case status (Table 1). For example, 
individuals with ASD were more likely to be male, first-born, from families with lower income, 
and born preterm or postterm. Individuals with ASD were also more likely to have mothers with 
gestational diabetes and hypertension, and parents with a history of neuropsychiatric disorders. 
The prevalence proportions of preterm and post-term birth were higher among individuals with 
ASD, especially those with co-occurring ID, than among those without ASD. 
 
The pattern of case distribution by gestational age at birth differed by sex (Supplementary Table 
1), although caution is warranted due to smaller strata sizes. Fewer females than males were 
affected by ASD with and without ID. Preterm and postterm births were more prevalent in both 
sexes among persons with ASD with and without ID. 
 
Gestational age at birth and risk of ASD with and without ID 
As shown in Table 2, the estimated prevalence of ASD decreased monotonically in births 
between 27 and 40 weeks, and then increased monotonically in births between 41 and 43 weeks. 
In Supplementary Table 2, we present results from sensitivity analysis on non-siblings. 
Prevalence estimates were slightly attenuated after accounting for unmeasured familial factors, 
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but the trend of elevated risk in preterm and postterm births persisted. Estimated ASD prevalence 
was substantially higher for very preterm and postterm births compared to infants born at 40 
weeks. For example, in Table 2, among individuals born at 27 and 43 weeks, the expected 
prevalence of ASD was 52.4 (95% CI: 42.3, 64.6) and 23.1 (95% CI: 21.3, 25.0) per 1,000, 
respectively; among those born at 40 weeks, the prevalence was estimated to be 19.8 (95% CI: 
19.3, 20.3) per 1,000. Also, the risk of co-occurring ID among cases increased with decreasing 
length of gestation. Among births at 27 weeks, of the expected 52.4 (95% CI: 42.3, 64.6) per 
1,000 affected individuals, about 41% of the cases were also expected to be affected by ID; in 
births at 40 weeks, the expected prevalence of co-occurring ID among cases was about 23%. A 
visualization of these estimates is provided in Supplementary Figure 1. 
 
Gestational age at birth and risk of ASD with/without ID in girls and boys 
Results from the sex-stratified analysis are presented in Table 3. The relationship between 
gestational age at birth and ASD without ID did not differ by sex (likelihood ratio test p-value = 
1), but the association between gestational age at birth and ASD with ID was different between 
males and females (likelihood ratio test p-value = 0.02). Expected prevalence of ASD without ID 
decreased continuously as gestational age at birth increased in both sexes. Risk of ASD with ID 
increased among postterm births in both males and females, with the strength of association in 
females being stronger. The expected prevalence of ASD with ID was 6.7 (95% CI: 6.3, 7.1) and 
8.0 (95% CI: 6.7, 9.5) per 1,000 among males born at 40 and 43 weeks, respectively; in other 
words, the risk of ASD with ID among males born at 43 weeks was about 1.2 times as high as 
the risk of ASD with ID among boys born at 40 weeks. This risk ratio (RR) among females born 
in these two gestational age at birth weeks was 1.4. In Supplementary Table 3, we presented this 
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RR and its associated 95% CI, as well as RR estimates for births in other weeks of gestation 
between the 27th and the 43rd weeks. Visualizations for these estimates are provided in 
Supplementary Figure 2. 
 
Comment 
Principal findings 
In this large population-based study, we investigated the relationship between gestational age at 
birth and ASD with and without ID and estimated ASD prevalence for births in each week of 
gestational age at birth. We also investigated whether these relationships differed in males and 
females. In summary, preterm and postterm births were associated with elevated risk of ASD 
with and without ID, and the pattern of these associations differed by sex. Risk of ASD without 
ID was higher in preterm births in both sexes and decreased continuously with increasing length 
of gestation. Risk of ASD with ID was higher in both preterm and postterm births in both sexes, 
with postterm birth in females being more highly associated with ASD with ID than that in males. 
 
Interpretation 
Consistent with previous findings,13,16 we observed a positive association between preterm birth 
and higher risk of ASD. Atladóttir reported an inverse association between gestational age at 
birth and ASD with a risk curve whose shape was very similar to the observations  reported here; 
however, the investigators did not separately consider ASD with and without ID.16 D’Onofrio 
investigated the association of gestational age at birth with ASD and other morbidities using data 
on over 3 million singleton births in Sweden between 1973 and 2008.13 In analyses using 
categories of gestational age, the investigators reported that compared to the risk of ASD for 
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individuals born at 37-42 weeks, the risk for those born at 23-27 weeks, 28-30 weeks, 31-32 
weeks, and 33-36 weeks were 3.2, 2.4, 1.7, and 1.3 times higher, respectively, also consistent 
with our results. Potential mechanisms that could explain this association include maternal health 
factors such as maternal pre-pregnancy obesity or infection during pregnancy,4,6 but this remains 
speculative. 
 
These findings support a positive association between postterm birth and higher risk of ASD. 
Gardener pooled results from 14 studies and reported an expected increase in the risk of ASD by 
14% among postterm births.14 In our study, individuals born in the 43rd week were 13% more 
likely to be affected by ASD in reference to those born in the 40th week. Though yet to be 
replicated, the increase in expected prevalence of ASD was driven mainly by that of ASD with 
ID in our sample. Potential mechanisms underlying this association may include a greater 
likelihood of birth complications resulting in brain injuries leading to increased risk of ASD and 
ID during postterm delivery.11,12 The strength of association between postterm birth and risk of 
ASD with ID was modest, and our continuous, flexible parameterization of gestational age at 
birth offered advantages in detecting weaker associations. Prior studies using categorical 
gestational age at birth intervals might have had limited statistical power to estimate this 
association.27–31 Alternatively, different reproductive and obstetric practices, as well as variations 
in ascertainment of gestational age at birth, ASD and ID across countries may also have 
influenced the observed relationships.28–32 
 
In the analysis, we did not observe sex differences in patterns of association between gestational 
age at birth and risk of ASD without ID. Expected prevalence of ASD regardless of ID status 
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were consistently higher in males than that in females. We did, however, observe different 
patterns of association between gestational age at birth and ASD with ID in males versus females. 
Females born postterm were at somewhat higher risk of ASD with ID than males born in the 
same week. It has been previously reported that ASD with ID might be genetically distinct from 
ASD with ID,2 and that specific cognitive skills and other ASD phenotypes may vary by sex.15 
Our findings suggest that the etiology of ASD with ID may be different in males and females. 
However, as ASD prevalence is known to exhibit strong male predominance, there were few 
females with ASD in our sample, so our estimates for females are imprecise and need to be 
interpreted with caution.  
 
Strengths 
The access to a large, population-based, high quality, prospectively collected data on prenatal 
and parental health, family income and other important measures is a main strength of this study. 
Multi-register data-linkage of a large volume of prospectively collect data enabled accurate and 
comprehensive capture of data on gestational age at birth and other pre- and perinatal variables, 
diagnoses, and parents’ health. Characteristics of our study sample (such as the male 
predominance in ASD prevalence, higher proportion of persons affected by ASD having parents 
with neuropsychiatric disorders, and mothers with gestational diabetes and hypertension) were in 
agreement with existing findings.14,24,29 Also, we were able to analyze the non-linearity of the 
association between gestational age at birth and ASD using GAMs. 
 
Limitations of the data 
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As with most observational epidemiologic data, some measurement or misclassification error is 
expected for gestational age at birth and other variables. However, nearly all gestational age at 
birth measures were based on ultrasound measures during the prenatal period, so the best 
estimates were used in the analysis and any measurement error is likely to be small and non-
differential with respect to outcome. We restricted our sample to singletons, so it is important to 
note that our findings cannot necessarily be generalized to individuals from multiple births. 
Finally, we did not examine potential mediation by general perinatal and neonatal risk factors, 
such as mode of delivery and more detailed birth complications. Such perinatal factors may 
increase risk of ASD and therefore may be on the causal pathway between gestational age at 
birth and ASD.14  
 
Conclusions 
We observed that preterm and postterm births were associated with elevated risk of ASD 
regardless of presence or absence of co-occurring ID, and the relationship between gestational 
age at birth and ASD with and without ID differed in males and females. Risk of ASD without 
ID was higher in preterm births, but not postterm births in both sexes. Risk of ASD with ID was 
higher in both preterm and postterm births in both sexes, with postterm birth in females being 
more highly associated with ASD with ID than that in males. These findings should be replicated 
using comparable approaches in other large data sets.  
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Table 1. Characteristics of the Stockholm Youth Cohort, born 1984-2007. 
 
Characteristics 
No ASD       
(N = 470,703) 
ASD            
(N = 10,025) 
ASD without ID 
(N = 7,657) 
ASD with ID 
(N = 2,368) 
Male, n (%) 239330 (50.8) 7103 (70.9) 5406 (70.6) 1697 (71.7) 
Birthweight-for-gestational age z-score, mean (SD 
a) 
0 (1) -0.1 (1.1) 0 (1.1) -0.2 (1.2) 
Maternal age (years) at delivery, mean (SD) 29.8 (5.2) 29.7 (5.5) 29.7 (5.5) 29.8 (5.6) 
Paternal age (years) at delivery, mean (SD) 32.8 (6.3) 32.8 (6.7) 32.5 (6.6) 33.5 (6.9) 
Gestational age at birth b, n (%)     
  Extremely preterm (<28 weeks) 580 (0.1) 49 (0.5) 28 (0.4) 21 (0.9) 
  Very preterm (28 - <32 weeks) 1193 (0.2) 51 (0.5) 34 (0.4) 17 (0.7) 
  Moderate to late preterm (32 - <37 weeks) 18943 (4.0) 541 (5.4) 397 (5.2) 144 (6.1) 
  Term (37 - <42 weeks) 413721 (87.9) 8458 (85.2) 6577 (85.9) 1971 (83.2) 
  Postterm (≥42 weeks) 36386 (7.7) 840 (8.4) 624 (8.1) 216 (9.1) 
Parity, n (%) 
    
    1 211913 (45.0) 4863 (48.5) 3866 (50.5) 997 (42.1) 
    2 170729 (36.3) 3299 (32.9) 2451 (32.0) 848 (35.8) 
    ≥3 88061 (18.7) 1863 (18.6) 1340 (17.5) 523 (22.1) 
Gestational hypertension, n (%) 14140 (3.0) 424 (4.2) 345 (4.5) 79 (3.3) 
Gestational diabetes, n (%) 2986 (0.6) 110 (1.1) 80 (1.0) 30 (1.3) 
Maternal smoking during pregnancy c, n (%) 65867 (14.0) 1634 (16.3) 1298 (17.0) 336 (14.2) 
Maternal neuropsychiatric history, n (%) 29773 (6.3) 916 (9.1) 741 (9.7) 175 (7.4) 
Paternal neuropsychiatric history, n (%) 22096 (4.7) 666 (6.6) 526 (6.9) 140 (5.9) 
Family income, n (%)  
   
    Q1 (Lowest) 68602 (14.6) 1585 (15.8) 1072 (14.0) 513 (21.7) 
    Q2 73429 (15.6) 1835 (18.3) 1371 (17.9) 464 (19.6) 
    Q3 74611 (15.9) 1810 (18.1) 1423 (18.6) 387 (16.3) 
    Q4 94207 (20.0) 1976 (19.7) 1581 (20.7) 395 (16.7) 
    Q5 (Highest) 159854 (34.0) 2819 (28.1) 2210 (28.9) 609 (25.7) 
Maternal region of origin, n (%)  
   
    Born in Sweden 358164 (76.1) 7743 (77.2) 6191 (80.9) 1552 (65.5) 
    Born in Europe outside Sweden 39276 (8.3) 895 (8.9) 657 (8.6) 238 (10.1) 
    Born outside Europe 73263 (15.6) 1387 (13.8) 809 (10.6) 578 (24.4) 
Birth year d, n (%)     
    1984 – 1988 83504 (98.5) 1249 (1.5) 890 (1.1) 359 (0.4) 
    1989 – 1993 108302 (97.8) 2474 (2.2) 1816 (1.6) 658 (0.6) 
    1994 – 1998 94569 (97.1) 2871 (2.9) 2206 (2.3) 665 (0.6) 
    1999 – 2003 94486 (97.7) 2266 (2.3) 1814 (1.9) 452 (0.4) 
    2004 – 2007 89842 (98.7) 1165 (1.3) 931 (1.0) 234 (0.3) 
a. SD: standard deviation. 
b. The minimum and maximum gestational age at birth was 23 and 45 weeks, respectively. 
c. 10.7% and 11.0% of maternal self-reported smoking during pregnancy data were missing among individuals with and without ASD 
diagnosis, respectively. 
d. Birth year was summarized in this table as birth year intervals and included in the GAM model as a continuous variable. Column-wise 
proportions were calculated to present prevalence of ASD with and without ID over birth year periods. 
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Table 2. Prevalence estimates and associated 95% confidence intervals (CI) by weeks of 
gestational age at birth for ASD (with or without ID), ASD without ID, and ASD with ID. 
 
Gestational 
age at birth 
(weeks) 
ASD 
Cases per 1,000 
(95% CI) 
ASD without ID 
Cases per 1,000 
(95% CI) 
ASD with ID 
Cases per 1,000 
(95% CI) 
27 52.4 (42.3, 64.6) 32.9 (25.6, 42.5) 21.3 (14.6, 29.7) 
28 44.1 (36.4, 53.2) 29.8 (24.1, 36.8) 16.0 (11.5, 21.8) 
29 37.7 (31.7, 44.6) 27.5 (23.0, 33.3) 12.7 (9.2, 16.5) 
30 33.1 (27.7, 38.9) 25.3 (21.5, 29.7) 10.4 (7.7, 13.8) 
31 30.0 (25.1, 35.0) 23.7 (20.3, 27.7) 8.9 (6.5, 11.9) 
32 28.1 (23.9, 32.7) 22.6 (19.6, 26.2) 8.1 (6.1, 10.8) 
33 27.0 (23.7, 30.8) 21.5 (19.0, 24.3) 7.7 (6.1, 10.0) 
34 26.7 (24.0, 29.4) 20.6 (18.8, 22.5) 7.6 (6.3, 9.3) 
35 26.4 (24.5, 28.4) 19.8 (18.3, 21.3) 7.5 (6.6, 8.8) 
36 25.8 (24.3, 27.3) 18.9 (17.8, 20.1) 7.3 (6.4, 8.1) 
37 24.4 (23.3, 25.6) 18.0 (17.2, 19.0) 6.6 (6.0, 7.3) 
38 22.5 (21.7, 23.3) 17.1 (16.5, 17.7) 5.7 (5.4, 6.2) 
39 20.9 (20.3, 21.4) 16.3 (15.8, 16.7) 5.0 (4.7, 5.3) 
40 19.8 (19.3, 20.3) 15.7 (15.3, 16.1) 4.6 (4.3, 4.8) 
41 19.8 (19.3, 20.3) 15.5 (15.1, 16.0) 4.6 (4.4, 4.8) 
42 20.9 (20.1, 21.6) 15.7 (15.0, 16.3) 5.1 (4.7, 5.5) 
43 23.1 (21.3, 25.0) 16.1 (15.1, 17.3) 6.2 (5.3, 7.3) 
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Table 3. Prevalence estimates and associated 95% confidence intervals (CI) by weeks of 
gestational age at birth for ASD overall, and ASD with and without ID in males and females. 
 
Gestational 
age at birth 
(weeks) 
ASD  
Cases per 1,000 
(95% CI) 
ASD without ID 
Cases per 1,000 
(95% CI) 
ASD with ID 
Cases per 1,000 
(95% CI) 
Male Female Male Female Male Female 
27 
72.1  
(56.4, 92.4) 
29.8  
(19.5, 44.7) 
46.7  
(34, 63.7) 
17.7 
 (13.3, 23.5) 
29.1  
(19.5, 45) 
11.2  
(5.7, 22.1) 
28 
59.9  
(47.9, 73.9) 
25.8  
(17.9, 36.8) 
42.6  
(32.6, 55.9) 
16.9  
(13, 22.3) 
21.9  
(15.3, 32.1) 
8.6  
(4.8, 15.8) 
29 
49.8  
(41.1, 61.4) 
22.8  
(16.6, 31.2) 
39.2  
(31.4, 49.7) 
16.2  
(12.5, 20.9) 
16.7  
(11.6, 23.9) 
7.3  
(4.1, 12.8) 
30 
43.2  
(34.5, 54.3) 
20.7  
(15.3, 28.1) 
36.3  
(29.7, 43.9) 
15.4  
(12.2, 19.7) 
13.3  
(9, 19.2) 
6.3  
(3.4, 11.5) 
31 
39.1  
(32.1, 47.7) 
19.5  
(14.2, 26.5) 
33.6  
(28.0, 40.3) 
14.7  
(12.1, 18.0) 
11.2  
(7.8, 17.1) 
5.9  
(3.3, 10.3) 
32 
36.8  
(30.8, 44.3) 
18.7  
(14.5, 24.8) 
31.2  
(27.0, 36.2) 
14.0  
(11.8, 16.7) 
10.1  
(7.3, 14.2) 
5.9  
(3.6, 9.7) 
33 
35.7  
(31.0, 40.8) 
18.4  
(14.6, 22.8) 
29.5  
(26.1, 33.6) 
13.3  
(11.4, 15.6) 
9.9  
(7.5, 13.1) 
6.1  
(4.1, 9.1) 
34 
35.5  
(31.6, 39.8) 
18.1  
(15.3, 21.5) 
27.9  
(25.1, 30.9) 
12.7  
(11.2, 14.8) 
9.7  
(7.8, 12) 
6.2  
(4.5, 8.3) 
35 
35.1  
(31.9, 38.4) 
17.7  
(15.5, 20.2) 
26.6  
(24.5, 29.1) 
12.2  
(10.9, 13.6) 
9.6  
(8.1, 11.5) 
6.1  
(4.7, 7.6) 
36 
34.2  
(31.9, 36.7) 
16.7  
(14.9, 18.8) 
25.4  
(23.6, 27.3) 
11.6  
(10.7, 12.7) 
9.4  
(8, 10.9) 
5.5  
(4.3, 6.7) 
37 
32.6  
(30.7, 34.4) 
15.4  
(14.2, 16.8) 
24.3  
(23.0, 25.6) 
11.1  
(10.2, 12) 
8.7  
(7.7, 9.8) 
4.5  
(3.8, 5.3) 
38 
30.6  
(29.3, 31.9) 
13.9  
(13.1, 14.9) 
23.3  
(22.3, 24.4) 
10.6  
(10, 11.2) 
7.8  
(7.2, 8.5) 
3.6  
(3.2, 4.1) 
39 
28.9  
(28.0, 29.9) 
12.7  
(12.1, 13.3) 
22.6  
(21.7, 23.3) 
10.1  
(9.7, 10.6) 
7.1  
(6.7, 7.6) 
2.9  
(2.7, 3.2) 
40 
27.9  
(26.9, 28.7) 
11.9  
(11.4, 12.4) 
22.0  
(21.3, 22.6) 
9.7  
(9.3, 10.1) 
6.7  
(6.3, 7.1) 
2.6  
(2.3, 2.8) 
41 
27.7  
(26.8, 28.5) 
11.6  
(11.1, 12.2) 
21.6  
(20.9, 22.3) 
9.2  
(8.8, 9.7) 
6.7  
(6.3, 7.1) 
2.6  
(2.3, 2.8) 
42 
28.4  
(27.0, 29.8) 
11.9  
(11.0, 12.8) 
21.5  
(20.5, 22.6) 
8.8  
(8.2, 9.5) 
7.2  
(6.5, 7.8) 
2.9  
(2.5, 3.3) 
43 
29.9  
(27.7, 32.7) 
12.6  
(10.9, 14.4) 
21.5  
(19.9, 23.5) 
8.4  
(7.7, 9.2) 
8.0  
(6.7, 9.5) 
3.6  
(2.7, 4.8) 
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Figure 1. Flow chart describing the cohort composition. IP: index person. ID: intellectual 
disability. 
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Supplementary Table 1. Number and column-wise percentages of males and females without 
ASD, with ASD without ID, and with ASD and ID by gestational age at birth periods. 
 
Gestational Age at Birth 
by Index Person Sex 
No ASD 
n (%) 
ASD 
n (%) 
ASD without ID 
n (%) 
ASD with ID 
n (%) 
Males     
  Extremely preterm (<28 weeks) 299 (0.1) 38 (0.5) 21 (0.4) 17 (1) 
  Very preterm (28 - <32 weeks) 627 (0.3) 32 (0.5) 21 (0.4) 11 (0.6) 
  Moderate to late preterm (32 - <37 weeks) 10074 (4.2) 391 (5.5) 294 (5.4) 97 (5.7) 
  Term (37 - <42 weeks) 208116 (87.0) 6023 (84.8) 4613 (85.3) 1410 (83.1) 
  Post-term (≥42 weeks) 20214 (8.4) 619 (8.7) 457 (8.5) 162 (9.5) 
Females     
  Extremely preterm (<28 weeks) 281 (0.1) 11 (0.4) 7 (0.3) 4 (0.6) 
  Very preterm (28 - <32 weeks) 566 (0.2) 19 (0.7) 13 (0.6) 6 (0.9) 
  Moderate to late preterm (32 - <37 weeks) 8860 (3.8) 149 (5.1) 102 (4.5) 47 (7.0) 
  Term (37 - <42 weeks) 205498 (88.8) 2522 (86.3) 1962 (87.2) 560 (83.5) 
  Post-term (≥42 weeks) 16168 (7.0) 221 (7.6) 167 (7.4) 54 (8.0) 
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Supplementary Table 2. Sensitivity analysis using data from persons unrelated to each other 
through biological mother or father to estimate prevalence and associated 95% confidence 
intervals (CI) by weeks of gestational age at birth for ASD (with or without ID), ASD without ID, 
and ASD with ID. 
 
Gestational 
age at birth 
(weeks) 
ASD 
Cases per 1,000  
(95% CI) 
ASD without ID 
Cases per 1,000  
(95% CI) 
ASD with ID 
Cases per 1,000  
(95% CI) 
27 40.0 (32.7, 49.1) 28.4 (22.4, 37.0) 16.5 (11.8, 23.8) 
28 34.7 (28.7, 41.4) 25.2 (20.2, 31.7) 13.1 (9.5, 18.5) 
29 30.9 (25.7, 36.9) 22.7 (18.6, 28.1) 11.1 (8.1, 15.0) 
30 28.6 (24.1, 33.9) 21.1 (17.4, 25.6) 9.7 (7.2, 13.0) 
31 27.0 (23.3, 31.5) 20.1 (16.9, 24.3) 8.7 (6.7, 11.4) 
32 26.1 (22.8, 29.8) 19.4 (16.7, 22.7) 8.1 (6.5, 10.4) 
33 25.5 (23.0, 28.4) 19.2 (16.7, 21.8) 7.8 (6.4, 9.6) 
34 25.0 (22.9, 27.3) 18.8 (16.8, 21.0) 7.5 (6.3, 8.8) 
35 24.2 (22.4, 26.1) 18.3 (16.7, 20.1) 7.0 (6.1, 8.2) 
36 22.9 (21.3, 24.5) 17.4 (16.1, 18.7) 6.5 (5.7, 7.3) 
37 21.3 (20.2, 22.4) 16.2 (15.3, 17.2) 5.8 (5.3, 6.4) 
38 19.6 (18.9, 20.4) 15.1 (14.4, 15.7) 5.2 (4.8, 5.6) 
39 18.2 (17.6, 18.7) 14.1 (13.6, 14.6) 4.6 (4.4, 4.9) 
40 17.2 (16.6, 17.7) 13.4 (13.0, 13.9) 4.2 (4.0, 4.5) 
41 16.6 (16.0, 17.2) 13.2 (12.7, 13.8) 4.0 (3.7, 4.3) 
42 16.3 (15.6, 17.3) 13.2 (12.4, 14.0) 3.9 (3.5, 4.4) 
43 16.5 (15.2, 18.0) 13.6 (12.3, 15.0) 4.0 (3.4, 4.8) 
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Supplementary Table 3. Risk ratios (RR) and associated 95% confidence intervals (CI) by weeks 
of gestational age at birth for ASD with and without ID in males and females, with reference to 
male and female infants born at 40 weeks. 
 
Gestational 
age at birth 
(weeks) 
ASD 
Cases per 1,000 (95% CI) 
ASD without ID 
Cases per 1,000 (95% CI) 
ASD with ID 
Cases per 1,000 (95% CI) 
Male Female Male Female Male Female 
27 2.6 (2.0, 3.4) 2.5 (1.6, 3.8) 2.1 (1.5, 2.9) 1.8 (1.4, 2.5) 4.4 (2.9, 6.8) 4.4 (2.2, 8.7) 
28 2.2 (1.7, 2.7) 2.2 (1.5, 3.2) 2.0 (1.5, 2.6) 1.8 (1.3, 2.3) 3.3 (2.3, 4.8) 3.4 (1.8, 6.2) 
29 1.8 (1.5, 2.2) 1.9 (1.4, 2.7) 1.8 (1.4, 2.3) 1.7 (1.3, 2.2) 2.5 (1.7, 3.7) 2.9 (1.5, 5.1) 
30 1.6 (1.2, 2.0) 1.8 (1.3, 2.4) 1.7 (1.4, 2.0) 1.6 (1.3, 2.1) 2.0 (1.3, 2.9) 2.5 (1.3, 4.6) 
31 1.4 (1.1, 1.7) 1.6 (1.2, 2.3) 1.5 (1.3, 1.9) 1.5 (1.2, 1.9) 1.7 (1.1, 2.6) 2.3 (1.3, 4.1) 
32 1.3 (1.1, 1.6) 1.6 (1.2, 2.1) 1.4 (1.2, 1.7) 1.5 (1.2, 1.8) 1.5 (1.1, 2.1) 2.3 (1.4, 3.8) 
33 1.3 (1.1, 1.5) 1.5 (1.2, 1.9) 1.3 (1.2, 1.5) 1.4 (1.2, 1.6) 1.5 (1.1, 2.0) 2.4 (1.6, 3.6) 
34 1.3 (1.1, 1.4) 1.5 (1.3, 1.8) 1.3 (1.1, 1.4) 1.3 (1.1, 1.5) 1.5 (1.2, 1.8) 2.4 (1.7, 3.3) 
35 1.3 (1.1, 1.4) 1.5 (1.3, 1.7) 1.2 (1.1, 1.3) 1.3 (1.1, 1.4) 1.4 (1.2, 1.7) 2.3 (1.8, 3.1) 
36 1.2 (1.1, 1.3) 1.4 (1.2, 1.6) 1.2 (1.1, 1.3) 1.2 (1.1, 1.3) 1.4 (1.2, 1.7) 2.1 (1.7, 2.7) 
37 1.2 (1.1, 1.3) 1.3 (1.2, 1.4) 1.1 (1.0, 1.2) 1.2 (1.0, 1.3) 1.3 (1.1, 1.5) 1.8 (1.4, 2.2) 
38 1.1 (1.0, 1.2) 1.2 (1.1, 1.3) 1.1 (1.0, 1.1) 1.1 (1.0, 1.2) 1.2 (1.1, 1.3) 1.4 (1.2, 1.7) 
39 1.0 (1.0, 1.1) 1.1 (1.0, 1.1) 1.0 (1.0, 1.1) 1.0 (1.0, 1.1) 1.1 (1.0, 1.2) 1.1 (1.0, 1.3) 
40 reference reference reference reference reference reference 
41 1.0 (0.9, 1.0) 1.0 (0.9, 1.1) 1.0 (0.9, 1.0) 1.0 (0.9, 1.0) 1.0 (0.9, 1.1) 1.0 (0.9, 1.2) 
42 1.0 (1.0, 1.1) 1.0 (0.9, 1.1) 1.0 (0.9, 1.0) 0.9 (0.8, 1.0) 1.1 (0.9, 1.2) 1.1 (0.9, 1.3) 
43 1.1 (1.0, 1.2) 1.1 (0.9, 1.2) 1.0 (0.9, 1.1) 0.9 (0.8, 1.0) 1.2 (1.0, 1.4) 1.4 (1.0, 1.9) 
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Supplementary Figure 1.  Estimated prevalence (per 1000) with associated 95% confidence 
intervals of ASD overall, ASD with and without ID by gestational age at birth in the Stockholm 
Youth Cohort, 1984-2007. 
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Supplementary Figure 2. Risk ratios with associated 95% confidence intervals of ASD with (left) 
and without (right) ID by gestational age at birth and sex. 
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